Grants for Unrestricted - Health

This funding opportunity provides financial support to organizations that deliver comprehensive services for individuals affected by sickle cell disease and related conditions, focusing on health equity and community engagement in designated regions of Ohio.

The USAID Accelerator Activity grant aims to provide $90.5 million over five years to improve health outcomes in four provinces of the Democratic Republic of the Congo by strengthening local health systems, reducing maternal and child mortality, improving nutrition, and promoting family planning and reproductive health, with a focus on local ownership, quality service, and community engagement.

Dear Prospective Applicants:The United States Agency for International Development Mission in Burundi (USAID Burundi) is seeking applications from qualified entities to implement a five-year Activity that focuses on Reproductive, Maternal, Newborn, and Child Health, Immunization, and Malaria (RMNCI+M) in Burundi, titled Kira Ukuze, as further described in Section A of this Notice of Funding Opportunity (NOFO). Eligibility for this award is not restricted.Eligible parties interested in submitting an application are encouraged to read this NOFO thoroughly to understand the type of program sought, application submission requirements, and selection process. Applications pursuant to this NOFO will be reviewed utilizing the following two-step process:Phase I: Technical ApplicationApplicants will submit a technical application that will be reviewed for responsiveness to the objectives of this NOFO and then evaluated according to the specific criteria provided in Section E. Eligible parties interested in submitting a technical application are encouraged to thoroughly read this NOFO to understand the type of activity sought, application submission requirements, and selection process. Selected applicants will advance to the Phase II of the selection process to submit a revised technical and cost application.Phase II: Revised Technical Application and Cost ApplicationApplicant(s) advancing to Phase II will receive a list of identified weaknesses, questions, and requests for clarifications resulting from the review of the technical applications. Responses to USAID Burundi feedback must be incorporated into the revised technical application. Subject to the availability of funds, USAID Burundi intends to make a single award to the applicant who best meets the objectives of this funding opportunity based on the merit review criteria described in Section E of this NOFO, subject to a risk assessment in accordance with ADS 303.3.9. While an award is anticipated as a result of this NOFO, USAID Burundi reserves the right to fund any or none of the initial technical applications submitted.

This program provides funding to research teams, patient advocacy groups, and healthcare organizations to develop innovative AI and machine learning solutions that improve the diagnosis of rare diseases, ultimately reducing diagnostic delays and enhancing patient care.

The ADAPT Program, initiated by the Advanced Research Projects Agency for Health (ARPA-H), aims to transform cancer care through innovative research focused on developing adaptive strategies for treating the evolution of cancer. This program seeks to create a dynamic cancer treatment platform capable of detecting tumor changes, updating treatment plans accordingly, and evaluating these plans through a novel clinical trial design. The goal is to match each patient’s evolving cancer with the most effective therapy, thereby revolutionizing cancer care by integrating new science and medical approaches to improve survival rates for patients with metastatic cancer.

THIS IS NOT A FUNDING OPPORTUNITY. The United States Agency for International Development (USAID) posts this Request for Information (RFI) to seek information/inputs from capable and interested organizations for an upcoming global social and behavior change (SBC) activity designed to advance local ownership and leadership of high-quality, evidence-informed SBC programs to improve health and development outcomes. A five-year activity is anticipated through full and open competition.Interested parties are requested to respond using the address provided on the attached RFI by August 21, 2023, 9:00AM EST.

This program provides funding to support tree planting and urban forestry projects in disadvantaged communities across Georgia, promoting long-term environmental benefits.

The five-year USAID National Family Planning and Adolescent Reproductive Health (FP/ARH) Activity (2024-2029) aims to improve family planning and adolescent reproductive health in the Philippines. It is a key component of the USAID Universal Health Care Project (UHCP) with the goal of improving health outcomes of underserved Filipinos. The FP/ARH Activity will help advance the Philippine governments efforts under the Universal Health Care law to improve the delivery of quality preventive, promotive care at the primary health care level. The Activity will contribute to achieving the Philippine governments health goals as follows: Increase the demand satisfied with modern FP methods among all women of reproductive age from 42 percent in 2022 to 75 percent by 2030; Reduce the adolescent birth rate from 25 per 1,000 girls (age 15-19) in 2022 to 12 per 1,000 girls by 2030; and Reduce the maternal mortality ratio from 144 per 100,000 live births in 2020 to less than 70 per 100,000 live births by 2030

The FY24 LCRP Translational Research Award mechanism supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may originate from a laboratory discovery, population-based studies, or a clinicians firsthand knowledge of patient care. The ultimate goal of translational research is to move a concept or observation forward into clinical application. However, Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside but can include a reciprocal flow of ideas and information between basic science and clinical science (bench to bedside and/or bedside to bench). Research applications only in the area of mesothelioma will not be accepted. This mechanism is intended to fund a broad range of translational studies with two different funding levels. The following are general examples, although not all-inclusive, of the type of research projects that would be appropriate to propose under the current program announcement:Funding Level 1: Advanced preclinical studies aimed at translating results from animal studies to applications with human samples/cohorts (The Translational Research Award is not intended to support initial mechanistic studies of a new target.) Late-stage preclinical work leading to/preparing for a clinical trial, e.g., Investigational New Drug (IND) application submission Correlative studies that are associated with an open/ongoing or completed clinical trial, e.g., projects that utilize biospecimens from clinical trials to improve clinical management of lung cancer and/or define new areas of research Projects that develop endpoints for clinical trialsFunding Level 2 Pilot clinical trials where limited clinical testing (e.g., small sample size) of a novel intervention is necessary to inform the next step in the continuum of translational researchPreliminary lung cancer relevant data to support the feasibility of the research hypotheses and research approaches are required.

This is a Notice of Funding Opportunity (NOFO) full package to solicit applications for one cooperative agreement from qualified entities to implement the Integrated Health Systems Strengthening (IHSS). Eligibility for this award is not restricted. The purpose of the Integrated Health System Strengthening (IHSS) program is to accelerate countries Health System Strengthening (HSS) efforts and achieve sustainable, equitable, and resilient health systems through locally-led, evidence-driven, and context-specific approaches to HSS. The primary goals are to advance primary health care (PHC), accelerate progress toward universal health coverage (UHC), and improve health outcomes. Investments in HSS help USAID reach its priority global health goals of preventing child and maternal deaths, controlling the HIV/AIDS epidemic, and combating infectious disease, which directly contributes to strengthening global health security. A strengthened and accessible health system is necessary to yield high-quality health services, which are essential for achieving sustainable improvements in health, promoting economic growth, and overall democratic development.Please find the entire full announcement in the "Related Documents" tab.Issue Date: May 07, 2024Q Due Date: May 21, 2024Closing Date: July 06, 2024Closing Time: 11:59 PM EST (Washington, DC)Amendment 1 with questions/answers has been added: May 31, 2024

This funding opportunity supports researchers in low- and middle-income countries to conduct important studies on infectious diseases that address local health challenges and build scientific capacity.

This funding opportunity supports organizations working to improve Peru's ability to prevent and respond to infectious diseases through enhanced surveillance, workforce development, and a focus on the interconnectedness of human, animal, and environmental health.

This funding opportunity supports organizations in Ohio to improve child passenger safety through education, outreach, and training initiatives across eight designated regions.

**Grant Title: Strengthening Global Health Security Program in Animal Health Sector** aims to gather feedback from organizations to enhance Uganda's ability to prevent, detect, and respond to zoonotic diseases by improving animal health systems, laboratory and surveillance infrastructure, and workforce development.

RFI Number: 7200AA24RFI00017Issuance Date: April 22, 2024Closing Date: May 20, 2024 5:00pm EDTSubject: Accelerating HIV Vaccine Research and Development in Low- and Middle-Income Countries (LMIC)To All Interested Respondents/Parties:The United States Agency for International Development (USAID) Bureau for Global Health (GH) is publishing this Request for Information (RFI) to obtain information and input that will be used to help make planning decisions. It may inform the design of future activities related to accelerating HIV vaccine research and development in low- and middle-income countries.This RFI is issued solely to collect expert inputs for information-gathering and planning purposes. This RFI does not constitute a Notice of Funding Opportunity (NOFO) or a Request for Proposals (RFP).Please also note the following:(a) responding to this Notice will not give any advantage to any organization or individual for any subsequent competition;(b) proprietary information should not be sent;(c) responses are not offers/applications and cannot be accepted by the U.S. Government to form a binding contract/award;(d) responses to this RFI are strictly voluntary, and USAID will not pay respondents for information provided in response to this RFI;(e) USAID reserves the right to, or not to, incorporate any/some/none of the comments received from RFI into subsequent solicitations or design documents and(f) applications or resumes will be discarded and should therefore not be included in your response.USAID posts its competitive business opportunities on www.sam.gov and www.grants.gov. This RFI does not restrict the Governments approach to a future solicitation or NOFO. It is the potential responders responsibility to monitor the site for the release of any further information.Questions regarding this announcement will not be accepted or answered. Not responding to this request does not preclude participation in any future solicitation, if any is issued. No basis for claims against the U.S. Government shall arise as a result of a response to this request for information or from the U.S. Governments use of such information.Submission Instructions:Only electronic submissions will be accepted. Responses to this RFI must be written in English.Respondents will only receive an electronic confirmation acknowledging receipt of their response; theywill not receive individualized feedback on any suggestions.USAID is requesting the public to submit short submissions outlining recommendations or otherinformation pertinent to the questions noted below. Responses should note the question numberaddressed and clearly relate back to the questions listed below, but responses do not need to addressevery question listed. All responses should provide sufficient detail and justification explaining why acertain recommendation is offered. Please also provide your name, title, organization, and contactinformation in the response.All submissions must adhere to the following format to ensure an efficient review: Must be written in English, size 11 Calibri font, not to exceed 20 pages total. The graphics subtextmay use a smaller font size. Submission file should be in PDF or Microsoft Word format. Submission file should be saved as ;lt;Entitys name;gt; Response to RFI 7200AA24RFI00017. The subject line for the submission email subject line must include Response to USAID/GHs RFI- Accelerating HIV Vaccine Research and Development in LMIC Must be submitted to Ms. Simone Cho at [email protected] with a copy to Mr. Elton Fortson [email protected] by the closing date and time noted at the beginning of this letter.Thank you for your interest in responding to this RFI. To learn more about partnering with USAID, pleasevisit www.work with usaid.gov.

This funding provides financial support to local education agencies for implementing depression screening programs for middle and high school students to improve early intervention and mental health support in schools.

This program provides funding to innovators developing non-invasive tear-based diagnostic technologies for continuous health monitoring and personalized treatment, initially targeting Dry Eye Disease.

This grant provides funding to improve primary health care services in Burkina Faso by enhancing service quality and community involvement, particularly for vulnerable groups like women, children, and people living with HIV/AIDS.

This initiative provides funding to local organizations in Thailand to strengthen the leadership and capabilities of civil society groups that support key populations affected by HIV, aiming to improve access to prevention, testing, and treatment services.

This award mechanism focuses on increasing implementation of evidence-based strategies to ensure that all Texans benefit from the cancer prevention knowledge that we currently have. CPRIT seeks to fund multilevel interventions to reduce cancer risk, disease burden, and cancer disparities. Modifiable risk behaviors include tobacco use, obesity, physical inactivity, unhealthy eating, alcohol use, sun exposure, HPV vaccination, Hepatitis B vaccination, and environmental/ occupational cancer exposures. Applications should also assess and address social determinants that contribute to cancer burden and disparities (e.g., cultural factors, unmet needs, access barriers). Interventions and communications should be structured to address the unique circumstances of the population to be served.